Literature DB >> 7055463

Posterior collagenous layer of the cornea. Ultrastructural classification of abnormal collagenous tissue posterior to Descemet's membrane in 30 cases.

G O Waring.   

Abstract

We studied the transmission electron microscopy of the abnormal collagenous tissue posterior to Descemet's membrane in 30 human corneas that represented 19 different diseases. We named this abnormal tissue the "posterior collagenous layer" of the cornea and classified it into three morphologic types: (1) banded posterior collagenous layer, characterized by 110-nm wide-spacing material, (2) fibrillar posterior collagenous layer, characterized by loose meshwork of collagenous fibrils 20 to 30 nm in diameter, and (3) fibrocellular posterior collagenous layer, characterized by fibroblasts in connective tissue. The published ultrastructural studies of 88 corneas that represented 13 different clinical disorders fit this classification well. The posterior collagenous layers often formed multiple lamellae, but no pattern was invariably associated with a specific clinical disorder. We think these multiple layers represent successive periods of deposition of collagen by a stressed corneal endothelium and provide a lifelong record of senescent and pathologic events.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7055463     DOI: 10.1001/archopht.1982.01030030124015

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  22 in total

Review 1.  Biomechanical relationships between the corneal endothelium and Descemet's membrane.

Authors:  Maryam Ali; VijayKrishna Raghunathan; Jennifer Y Li; Christopher J Murphy; Sara M Thomasy
Journal:  Exp Eye Res       Date:  2016-09-14       Impact factor: 3.467

2.  PI 3-kinase/Rac1 and ERK1/2 regulate FGF-2-mediated cell proliferation through phosphorylation of p27 at Ser10 by KIS and at Thr187 by Cdc25A/Cdk2.

Authors:  Jeong Goo Lee; EunDuck P Kay
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-21       Impact factor: 4.799

Review 3.  Fuchs endothelial corneal dystrophy.

Authors:  Hussain Elhalis; Behrooz Azizi; Ula V Jurkunas
Journal:  Ocul Surf       Date:  2010-10       Impact factor: 5.033

4.  The corneal endothelium and Descemet's membrane in the iridocorneal endothelial syndrome.

Authors:  J M Portis; R L Stamper; W H Spencer; R G Webster
Journal:  Trans Am Ophthalmol Soc       Date:  1985

5.  Posterior polymorphous corneal dystrophy: a disease characterized by epithelial-like endothelial cells which influence management and prognosis.

Authors:  J H Krachmer
Journal:  Trans Am Ophthalmol Soc       Date:  1985

6.  Bilateral reversible corneal edema associated with amantadine use.

Authors:  Salomon Esquenazi
Journal:  J Ocul Pharmacol Ther       Date:  2009-12       Impact factor: 2.671

7.  Immuno-electron labelling of matrix components in congenital hereditary endothelial dystrophy.

Authors:  W Sekundo; G E Marshall; W R Lee; C M Kirkness
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-06       Impact factor: 3.117

8.  Interleukin-1β enhances cell migration through AP-1 and NF-κB pathway-dependent FGF2 expression in human corneal endothelial cells.

Authors:  Jeong Goo Lee; Martin Heur
Journal:  Biol Cell       Date:  2013-03-07       Impact factor: 4.458

9.  Congenital hereditary corneal oedema of Maumenee: its clinical features, management, and pathology.

Authors:  C M Kirkness; A McCartney; N S Rice; A Garner; A D Steele
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

10.  Compositional differences between infant and adult human corneal basement membranes.

Authors:  Andrea Kabosova; Dimitri T Azar; Gregory A Bannikov; Kevin P Campbell; Madeleine Durbeej; Reza F Ghohestani; Jonathan C R Jones; M Cristina Kenney; Manuel Koch; Yoshifumi Ninomiya; Bruce L Patton; Mats Paulsson; Yoshikazu Sado; E Helene Sage; Takako Sasaki; Lydia M Sorokin; Marie-France Steiner-Champliaud; Tung-Tien Sun; Nirmala Sundarraj; Rupert Timpl; Ismo Virtanen; Alexander V Ljubimov
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-11       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.